1 of 26

Elicitation Training for Survival Extrapolation

��

January 2025

2 of 26

Instructions

  • Suggested training materials including content specific to survival extrapolation
  • Edit and incorporate within any other training content as you wish!
    • But please could you give an acknowledgement, referring to the slides provided at https://shelf.sites.sheffield.ac.uk/survival-extrapolation

3 of 26

Contents

  1. General probability elicitation

  • Survival extrapolation

4 of 26

General probability elicitation

  •  

5 of 26

My uncertainty about the distance

 

6 of 26

My uncertainty about the distance

  • I think distances around 200 miles are more likely than distances around 300 miles

7 of 26

My uncertainty about the distance

  • For the same reward, I’d have no preference on betting whether the distance is inside or outside the red section (190-240 miles)

8 of 26

Poor choices of distribution

  • Obtaining a suitable distribution is hard, but easy to identify inappropriate representations of uncertainty

9 of 26

How we obtain probability distributions

  • We do not ask you to specify distributions directly
  • We will ask you to make a small number of probability judgements
    • We will then choose a distribution consistent with these, and present to you for feedback

10 of 26

Biases

  • A large body of research on how people make probability judgements, and what can go wrong.
  • Some biases to be aware of:
    • Overconfidence
    • Anchoring
    • Availability

11 of 26

Overconfidence

  • Out of all occasions we are ‘90% sure’ we are right, we should be right 90% of the time (so wrong 10% of the time)
    • but experiments typically show when we claim to be 90% sure we are right, we are right far less often, e.g. 60% of the time

12 of 26

Overconfidence

  • Unlikely events/small probabilities difficult to think about
    • tails of a distribution should not look too plausible

13 of 26

Anchoring

Undue influence of a single value. Example:

  • Q1a Is the population of South Africa greater/less than 8 million?
  • Q2a Estimate the population of South Africa. Answers in millions:

25, 17, 11, 14, 14, 10, 15, 17, 11, 15, 100, 20, 12, 30, 11, 21, 20, 10, 16, 20, 18

14 of 26

Anchoring

  • Q1b Is the population of South Africa greater/less than 85 million?
  • Q2b Estimate the population of South Africa. Answers in millions:

60, 75, 70, 55, 60, 60, 50, 70, 50, 85, 100, 45, 35, 15, 90, 90

15 of 26

Availability

  • Probability linked to how easily some event can be recalled
  • Some events more memorable than others
  • Need to be cautious with anecdotal evidence; individual patients

16 of 26

Elicitation Protocol

  • We will use the Sheffield Elicitation Framework (SHELF) to elicit probability judgements in a way that reduces these biases, whilst enabling sharing of expertise
  • You will be asked to make probability judgements individually first, without conferring
  • Judgements will be presented to the group (next meeting)
    • Typically suggests more uncertainty than in any one individual; provides multiple anchors

17 of 26

Elicitation Protocol

  • Facilitated group discussion will follow
    • Includes discussion of qualitative opinions
  • Group will propose single set of probability judgements from perspective of a "Rational Impartial Observer" as a fair way of reporting any residual disagreement

18 of 26

Survival extrapolation

  • Survival data from trial available: presented as survivor functions
  • Aim is to quantify uncertainty about extrapolated survival probabilities
  • Will review survivor/hazard functions
    • Will consider qualitative judgements about hazard functions

19 of 26

Survivor function

20 of 26

Hazard functions

  •  

21 of 26

Hazard functions

  • e.g. consider cohort-level ‘risk of death’ over a 6 month period. For those surviving this period, does the cohort-level risk of death over the next 6 months
    • stay the same;
    • decrease;
    • increase?
  • Factors influencing hazard include characteristics of patient group, disease natural history, and mechanism of treatment action

22 of 26

UK female population hazard function

23 of 26

Survivor and hazard functions

24 of 26

Model-based versus expert extrapolation

From NICE TA621 Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer

25 of 26

  • Questions?

  • Training exercise

26 of 26

References

  • Office for National Statistics (ONS), released 11 January 2024, ONS website, statistical bulletin, National life tables – life expectancy in the UK: 2020 to 2022
  • Loprinzi CL. Laurie JA. Wieand HS. Krook JE. Novotny PJ. Kugler JW. Bartel J. Law M. Bateman M. Klatt NE. et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. Journal of Clinical Oncology. 12(3):601-7, 1994.
  • Therneau T (2024). A Package for Survival Analysis in R. R package version 3.7-0, https://CRAN.R-project.org/package=survival.
  • NICE (2021). Single Technology Appraisal: Osimertinib for untreated EGFR-positive non-small-cell lung cancer [ID1302]; Committee Papers. https://www.nice.org.uk/guidance/ta654/documents/committee-papers-5